Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
3.650
+0.220 (6.41%)
At close: Dec 19, 2025, 4:00 PM EST
3.630
-0.020 (-0.55%)
After-hours: Dec 19, 2025, 6:03 PM EST
Larimar Therapeutics Market Cap
Larimar Therapeutics has a market cap or net worth of $312.4 million as of December 19, 2025. Its market cap has decreased by -19.47% in one year.
Market Cap
312.40M
Enterprise Value
141.32M
1-Year Change
-19.47%
Ranking
Category
Stock Price
$3.65
Market Cap Chart
Since May 29, 2020, Larimar Therapeutics's market cap has increased from $113.38M to $312.40M, an increase of 175.53%. That is a compound annual growth rate of 19.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 312.40M | 26.51% |
| Dec 31, 2024 | 246.93M | 23.61% |
| Dec 29, 2023 | 199.77M | 11.79% |
| Dec 30, 2022 | 178.70M | -6.49% |
| Dec 31, 2021 | 191.10M | -41.88% |
| Dec 31, 2020 | 328.78M | 189.97% |
| May 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.35B |
| Johnson & Johnson | 497.21B |
| AbbVie | 400.88B |
| UnitedHealth Group | 296.59B |
| AstraZeneca | 283.55B |
| Novartis AG | 261.76B |
| Merck & Co. | 250.91B |
| Abbott Laboratories | 218.14B |